589 related articles for article (PubMed ID: 25860234)
1. Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation.
Scherer F; Navarrete MA; Bertinetti-Lapatki C; Boehm J; Schmitt-Graeff A; Veelken H
Leuk Lymphoma; 2016; 57(1):151-60. PubMed ID: 25860234
[TBL] [Abstract][Full Text] [Related]
2. Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL.
Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Saigo K; Nakamachi Y; Kumagai S; Ohno H; Tanabe S; Uchida M; Yasuda N
Leukemia; 2004 Apr; 18(4):826-31. PubMed ID: 14990977
[TBL] [Abstract][Full Text] [Related]
3. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity.
Lossos IS; Levy R; Alizadeh AA
Leukemia; 2004 Nov; 18(11):1775-9. PubMed ID: 15385936
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide mutational signatures revealed distinct developmental paths for human B cell lymphomas.
Ye X; Ren W; Liu D; Li X; Li W; Wang X; Meng FL; Yeap LS; Hou Y; Zhu S; Casellas R; Zhang H; Wu K; Pan-Hammarström Q
J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33136155
[TBL] [Abstract][Full Text] [Related]
5. What do somatic hypermutation and class switch recombination teach us about chronic lymphocytic leukaemia pathogenesis?
Oppezzo P; Dighiero G
Curr Top Microbiol Immunol; 2005; 294():71-89. PubMed ID: 16323428
[TBL] [Abstract][Full Text] [Related]
6. Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate.
Ouadani H; Ben-Mustapha I; Ben-Ali M; Larguèche B; Jovanic T; Garcia S; Arcangioli B; Elloumi-Zghal H; Fathallah D; Hachicha M; Masmoudi H; Rougeon F; Barbouche MR
Mol Immunol; 2016 Nov; 79():77-82. PubMed ID: 27716525
[TBL] [Abstract][Full Text] [Related]
7. Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression.
Gagyi E; Balogh Z; Bödör C; Timár B; Reiniger L; Deák L; Csomor J; Csernus B; Szepesi A; Matolcsy A
Haematologica; 2008 Dec; 93(12):1822-8. PubMed ID: 18945749
[TBL] [Abstract][Full Text] [Related]
8. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas.
Greeve J; Philipsen A; Krause K; Klapper W; Heidorn K; Castle BE; Janda J; Marcu KB; Parwaresch R
Blood; 2003 May; 101(9):3574-80. PubMed ID: 12511417
[TBL] [Abstract][Full Text] [Related]
9. AID targeting in antibody diversity.
Pavri R; Nussenzweig MC
Adv Immunol; 2011; 110():1-26. PubMed ID: 21762814
[TBL] [Abstract][Full Text] [Related]
10. Activation-induced deaminase (AID)-directed hypermutation in the immunoglobulin Smu region: implication of AID involvement in a common step of class switch recombination and somatic hypermutation.
Nagaoka H; Muramatsu M; Yamamura N; Kinoshita K; Honjo T
J Exp Med; 2002 Feb; 195(4):529-34. PubMed ID: 11854365
[TBL] [Abstract][Full Text] [Related]
11. Analysis of somatic hypermutations in the IgM switch region in human B cells.
Horiuchi K; Imai K; Mitsui-Sekinaka K; Yeh TW; Ochs HD; Durandy A; Nonoyama S
J Allergy Clin Immunol; 2014 Aug; 134(2):411-9. PubMed ID: 24836470
[TBL] [Abstract][Full Text] [Related]
12. APE1 is dispensable for S-region cleavage but required for its repair in class switch recombination.
Xu J; Husain A; Hu W; Honjo T; Kobayashi M
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17242-7. PubMed ID: 25404348
[TBL] [Abstract][Full Text] [Related]
13. Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21).
Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Suzuki A; Saigo K; Kawano S; Takenokuchi M; Kumagai S; Matsuo Y; Koizumi T; Takeuchi M
Eur J Haematol; 2005 Jan; 74(1):11-9. PubMed ID: 15613101
[TBL] [Abstract][Full Text] [Related]
14. Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia.
Marantidou F; Dagklis A; Stalika E; Korkolopoulou P; Saetta A; Anagnostopoulos A; Laoutaris N; Stamatopoulos K; Belessi C; Scouras Z; Patsouris E
Blood Cells Mol Dis; 2010 Apr; 44(4):262-7. PubMed ID: 20117026
[TBL] [Abstract][Full Text] [Related]
15. ATM is not required in somatic hypermutation of VH, but is involved in the introduction of mutations in the switch mu region.
Pan-Hammarström Q; Dai S; Zhao Y; van Dijk-Härd IF; Gatti RA; Børresen-Dale AL; Hammarström L
J Immunol; 2003 Apr; 170(7):3707-16. PubMed ID: 12646636
[TBL] [Abstract][Full Text] [Related]
16. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.
Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A
Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139
[TBL] [Abstract][Full Text] [Related]
17. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.
Kotani A; Okazaki IM; Muramatsu M; Kinoshita K; Begum NA; Nakajima T; Saito H; Honjo T
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4506-11. PubMed ID: 15767564
[TBL] [Abstract][Full Text] [Related]
18. Separate domains of AID are required for somatic hypermutation and class-switch recombination.
Shinkura R; Ito S; Begum NA; Nagaoka H; Muramatsu M; Kinoshita K; Sakakibara Y; Hijikata H; Honjo T
Nat Immunol; 2004 Jul; 5(7):707-12. PubMed ID: 15195091
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of activation-induced cytidine deaminase in B cells.
Muto T; Okazaki IM; Yamada S; Tanaka Y; Kinoshita K; Muramatsu M; Nagaoka H; Honjo T
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2752-7. PubMed ID: 16477013
[TBL] [Abstract][Full Text] [Related]
20. Identification of DNA cleavage- and recombination-specific hnRNP cofactors for activation-induced cytidine deaminase.
Hu W; Begum NA; Mondal S; Stanlie A; Honjo T
Proc Natl Acad Sci U S A; 2015 May; 112(18):5791-6. PubMed ID: 25902538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
